This is a different technology. I don’t think for autologous treatments like this that 3D would be a specifically relevant technology. I believe for many of those uses you’re usually talking about broad application to huge vats of cell material that is undifferentiated and manufactured.
In these cases they are processing for individual patients, one at a time, and I do not think it has major relevance in these instances.
Market Data 
Markets 
AI
